Sanoculis is a late-stage company with CE mark and initial commercial revenues in EU. Sanoculis develops and markets the MIMS® (Minimally Invasive Micro Sclerostomy) device and surgery for the treatment of the Glaucoma. MIMS® is simple, fast, and minimally invasive requiring no stitches, eye-patch, implant or stent. It is designed to reduce the caring costs […]
Innoptix is committed to driving digital transformation in eyecare, working with leading professionals and clinics to build impactful solutions. We design and develop specialist digital tools that address unique challenges faced by clinics, surgeons, and patients in the eyecare sector. From intuitive mobile applications to desktop platforms that integrate seamlessly into existing workflows, our products […]
Sanoculis is an Israel-based company which develops and markets three novel surgical techniques for the treatment of Glaucoma: MIMS® (Minimally Invasive Micro Sclerostomy), inferonasal MIMS® (after failed Trab) and MINT® (Minimally Invasive Nasal Trabeculostomy). These techniques are simple, fast, and minimally invasive. These techniques require no stitches, eye-patch, implant or stent and thus leave nothing […]
CILIATECH develops INTERCIL, a new hydrophilic acrylic implant, permanently implanted in the supraciliary space, for the treatment of glaucoma. Devices utilizing the supraciliary space can provide a long-term intraocular pressure (IOP) decrease, but long-term success depends on correct surgical placement. Supraciliary devices may provide greater effectiveness than those which can be obtained with the plethora […]
Ophtec’s patented Transitional Conic Technology (TCT) represents a significant advancement in IOL design. It features an optimized Toric optical surface with enhanced tolerance to lens misalignment and rotation. This technical solution enables a more precise astigmatic correction, ensuring stable and natural vision outcomes, even under suboptimal conditions. TCT is a computer-guided system that uses precise, […]
ColorPhi™ delivers a transformative visual augmentation platform for ophthalmology and clinical diagnostics by enhancing visual interpretation of color, contrast, and multispectral data. Initially designed for individuals with color vision deficiency (CVD), ColorPhi’s patented visual algorithms have expanded to support low vision and enable the real-time visualization of electromagnetic spectrum (EMS) data, including IR and UV […]
Medevise Consulting is a full service consultancy that enables new technology start ups to access the European market by guiding them through each step of the approval process. We can help navigate market access, manage clinical trials, and develop and implement regulatory strategies. Our services enable innovators to move from the early phase of uncertainty […]
Glaucoma surgery is a rapidly evolving therapy that has demonstrated substantial benefit yet has fallen short of offering an effective means for the management of all glaucoma patients. Our proprietary Calibreye™ Titratable Glaucoma Therapyä (TGT) Surgical System aims to provide next-generation IOP management, safety without sacrificing efficacy, a familiar delivery technique, and the ability to […]
NovaSight is a growing MedTech company dedicated to revolutionizing pediatric vision care through advanced technology and bringing it into the digital age. Founded in 2016, NovaSight has experienced rapid growth by delivering complete end-to-end eye tracking-based solutions for accurate diagnostic, treatment and prevention of early vision disorders. NovaSight’s flagship product CureSight™, is an eye tracking-based device for […]
